{"entity":{"id":"paper-nur-kuwait-colorectal-screening-cost-sci-rep-2025","kind":"paper","name":"Cost effectiveness of three colorectal cancer screening methods in Kuwait","aka":[],"tldr":"A decision model for Kuwait found that a stool blood test followed by colonoscopy or sigmoidoscopy cost less and gave more quality-adjusted life years than no screening, and more than colonoscopy or sigmoidoscopy alone.","summary":"Published as \"Cost effectiveness analysis of three colorectal cancer screening modalities in Kuwait\". A decision tree model from the perspective of the Kuwait Ministry of Health as payer compared a faecal occult blood test followed by colonoscopy or sigmoidoscopy, colonoscopy alone, sigmoidoscopy alone and no screening, over 10 years after diagnosis.","asOf":"2026-11-16","links":[{"label":"Sci Rep 2025","url":"https://doi.org/10.1038/s41598-025-91119-4"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/40025065/"}],"tags":[],"related":[],"cancers":["colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["kuwait-cancer-registry","kuwait-ministry-of-health"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"Scientific Reports","year":2025,"doi":"10.1038/s41598-025-91119-4","pmid":"40025065","authors":"Nur AM, Aljunid SM, Tolma EL, et al.","paperType":"observational","findings":["Stool blood test followed by colonoscopy or sigmoidoscopy: 7.7 quality-adjusted life years at US$3,573; no screening: 7.2 at US$4,084.","Sigmoidoscopy alone or colonoscopy alone: 6.8 quality-adjusted life years each, at US$4,905 and US$5,002.","The paper cites Kuwait Cancer Registry data: 2,710 colorectal cancers from January 2010 to December 2019, about 10.2% of all cancers, and a rate of 13.2 per 100,000."],"whatItMeans":"It gives Kuwait's health planners a local estimate in favour of a stool-test-first screening programme, and records that the reach of the Ministry's 2015 early diagnosis programme is not known.","caveats":["A model, not a trial: it rests on several stated assumptions, such as an equal chance of each stage at diagnosis, and the cost of setting up a national programme was not included.","Costs are from the provider's side only; costs to patients, such as travel and lost earnings, were left out."]},"route":"/key-papers/paper-nur-kuwait-colorectal-screening-cost-sci-rep-2025/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}],"institution":[{"id":"kuwait-cancer-registry","kind":"institution","name":"Kuwait Cancer Registry","route":"/institutions/kuwait-cancer-registry/"},{"id":"kuwait-ministry-of-health","kind":"institution","name":"Ministry of Health, Kuwait","route":"/institutions/kuwait-ministry-of-health/"}]}}